FDA Inspection 945705 — LEK Pharmaceuticals d.d.

LEK Pharmaceuticals d.d. — FEI 3002807463

The FDA completed an inspection of LEK Pharmaceuticals d.d. on September 25, 2015 in Lendava. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lendava (Slovenia)